Anifrolumab Malignancy and Serious Infections Study

Trial Identifier:	D3461R00046
Sponsor:	AstraZeneca
Collaborator:	IQVIA
Start Date:	November 2025
Primary Completion Date:	November 2031
Study Completion Date:	November 2031
Condition:	Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.